Goldenwell Biotech annual ebitda
2022
2023
2024
2025
Goldenwell Biotech EBITDA Growth & History (GWLL)
Goldenwell Biotech's calculated EBITDA was −$288,071 for fiscal 2025.
View full Goldenwell Biotech company overviewGoldenwell Biotech annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$288,071 | −$164,973 | — |
| 2024 | 2024-12-31 | −$123,098 | −$7,272 | — |
| 2023 | 2023-12-31 | −$115,826 | $869,279 | — |
| 2022 | 2022-12-31 | −$985,105 | — | — |
Goldenwell Biotech quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$34,776 | −$6,576 | — |
| Q1 2026 | 2026-03-31 | −$15,506 | $20,930 | — |
| Q4 2025 | 2025-12-31 | −$197,640 | — | — |
| Q3 2025 | 2025-09-30 | −$25,795 | — | — |
| Q2 2025 | 2025-06-30 | −$28,200 | — | — |
| Q1 2025 | 2025-03-31 | −$36,436 | — | — |
Goldenwell Biotech ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Goldenwell Biotech's ebitda increased from −$985,105 to −$288,071, a change of $697,034. The latest reported quarter, Q2 2026, shows −$34,776.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Goldenwell Biotech source filings ↗